|
C7ORF64 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.946840E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.435800E-01 |
| Normal-vs-Stage2 |
2.204000E-01 |
| Normal-vs-Stage3 |
1.229760E-01 |
| Normal-vs-Stage4 |
1.802170E-01 |
| Stage1-vs-Stage2 |
2.546200E-01 |
| Stage1-vs-Stage3 |
6.150100E-02 |
| Stage1-vs-Stage4 |
3.359000E-01 |
| Stage2-vs-Stage3 |
1.127840E-01 |
| Stage2-vs-Stage4 |
1.215840E-01 |
| Stage3-vs-Stage4 |
9.810800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.479000E-01 |
| Normal-vs-AfricanAmerican |
2.149000E-01 |
| Normal-vs-Asian |
8.435400E-01 |
| Caucasian-vs-AfricanAmerican |
3.947400E-01 |
| Caucasian-vs-Asian |
6.660000E-01 |
| AfricanAmerican-vs-Asian |
6.134000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.466400E-01 |
| Normal-vs-Female |
2.182800E-01 |
| Male-vs-Female |
4.399200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.640600E-01 |
| Normal-vs-Extreme_Weight |
8.591400E-01 |
| Normal-vs-Obese |
3.117000E-01 |
| Normal-vs-Extreme_Obese |
8.876800E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.780400E-01 |
| Normal_Weight-vs-Obese |
2.720800E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.983800E-01 |
| Extreme_Weight-vs-Obese |
2.790000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.293000E-01 |
| Obese-vs-Extreme_Obese |
5.989000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.897800E-01 |
| Normal-vs-Age(41-60Yrs) |
9.101800E-02 |
| Normal-vs-Age(61-80Yrs) |
4.076800E-01 |
| Normal-vs-Age(81-100Yrs) |
7.729600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.487440E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.181200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.235200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.745200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.862600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.864400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.583100E-03 |
| Normal-VS-Type2 PRCC |
6.132000E-02 |
| Normal-VS-KIRP CIMP |
3.551000E-04 |
| Normal-VS-Unclassified PRCC |
3.445800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.16009999999267E-05 |
| Type1 PRCC-VS-KIRP CIMP |
2.49119999999881E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
5.309200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.069960E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.600200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.903400E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.715400E-01 |
| Normal-vs-N1 |
2.549400E-01 |
| Normal-vs-N2 |
1.385740E-02 |
| N0-vs-N1 |
7.021400E-01 |
| N0-vs-N2 |
2.324000E-01 |
| N1-vs-N2 |
2.898600E-01 |
|
|
